Prostate cancer decisions — 2023

The Veteran's prostate cancer is presumed to be due to in-service herbicide exposure at Udorn RTAFB, Thailand. Service connection for prostate cancer residuals is granted.

The Veteran is granted a total disability rating based on individual unemployability due to service-connected disabilities, effective August 10, 2022. The claim for TDIU is dismissed as the service-connected prostate cancer alone grants a 100% schedular rating and special monthly compensation (SMC) under 38 U.S.C. § 1114(s).

The Veteran's appeal for prostate cancer has been withdrawn. His TDIU claim is granted, and the Board finds that his service-connected disabilities prevent him from securing or following a substantially gainful occupation. The claims for headaches, hemorrhoids, peripheral neuropathy, skin disorder (other than alopecia areata), and back disability are all remanded.

The Board denied service connection for prostate cancer, ED, and a mental condition as secondary to prostate cancer due to exposure at Camp LeJeune. The claims were reopened based on new evidence received within one year of the April 2017 rating decision.

The Board denied service connection for throat tumor due to the lack of evidence showing a current disability or functional impairment after October 2011. The prostate cancer and erectile dysfunction claims are remanded for further development.,Additional research is needed regarding the Veteran's exposure to ionizing radiation, particularly considering his assertions of more frequent exposure than others at the Nevada Test Site.

The Veteran's appeal is remanded due to the need for further evaluation and consideration of his claims, particularly regarding prostate cancer and fatigue. His testicular condition claim also requires additional review.

Service connection is granted for prostate cancer and hypertension associated with herbicide agent exposure under the PACT Act.,The Veteran's service in Korea from June 1968 to January 1969 was presumed due to his exposure to herbicide agents.

The Board denied service connection for a back disability, left ear hearing loss, and a psychiatric disorder (claimed as secondary to prostate cancer and skin cancer).,The Veteran's claims were not supported by the evidence of record.

The Board denied the Veteran's claim for service connection for prostate cancer, finding no evidence of herbicide exposure during his service aboard the U.S.S. Kitty Hawk and concluding that there is insufficient medical evidence to establish a link between his current condition and service.

The Veteran's claims for service connection for type II diabetes mellitus, prostate cancer, Alzheimer's disease, and hypercholesteremia have been denied.,Service connection was not established as the conditions were not shown to be related to active duty service.

The Board has remanded the case due to insufficient evidence regarding exposure to burn pits and toxic substances, as well as the need for a TERA examination to determine the etiology of the Veteran's prostate cancer and sleep apnea.

The Board denied the Veteran's claim for service connection for residuals of radiation therapy for service-connected prostate cancer, including bowel incontinence, finding that there was no evidence to support a secondary or aggravation relationship.

The Board has granted service connection for type II diabetes mellitus and prostate cancer, both presumed due to herbicide agent exposure while stationed at Takhli RTAFB. The effective date is not specified as the claim was reopened.

The Veteran's prostate cancer claim is remanded due to potential exposure to Camp Lejeune contaminated water and asbestos at the Marine Corps Reserve Training Center in Middlesex, NJ.,Head injury residuals and headaches claims are both remanded as new evidence suggests these conditions may be related to INACDUTRA service.

The Board denied the Veteran's claim for revision of his May 2001 rating decision, which assigned a 30 percent rating from June 1, 2001. The Board found no CUE and concluded that the evidence did not support higher ratings based on urinary leakage or frequency.

Service connection for prostate cancer is denied as there was no in-service disease or injury indicative of the condition, and it is not related to service.,Service connection for left foot disability is denied due to lack of evidence showing a disease or injury during service.,Service connection for right foot disability is denied due to lack of evidence showing a disease or injury during service.,Service connection for left CTS is denied as there was no in-service onset and it is not related to service.,Service connection for right CTS is denied as it is not caused or aggravated by a service-connected disability.,Service connection for vision disability (bilateral cataracts, bilateral dry eye syndrome, bilateral vitreous floaters, and bilateral pinguecula) is denied due to lack of evidence showing a disease or injury during service.,Service connection for lumbar spine disability is denied as there was no in-service onset and it is not related to service.,Service connection for cervical spine disability is denied as there was no in-service onset and it is not related to service.,Service connection for vitiligo is denied due to lack of evidence showing a disease or injury during service.

The Veteran's claim for an effective date of November 18, 2014, for service connection for prostate cancer is granted. The issue of a higher initial rating for prostate cancer and bladder cancer with stress urinary incontinence and erectile dysfunction remains pending.

The Board dismissed all appeals due to the Veteran's withdrawal of his appeal prior to a decision being made.

The Board has denied the Veteran's claim for service connection for prostate cancer, finding that the evidence does not support a link between his current diagnosis and his military service at Camp Lejeune.

The Veteran's hypertension is granted as secondary to his service-connected diabetes mellitus. The prostate cancer residuals are rated at the maximum schedular level of 60 percent for urinary leakage, and a noncompensable rating remains for the prostatectomy surgical scar.